Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 24 citing articles:

Prognostic Scores and Survival Rates by Etiology of Hepatocellular Carcinoma: A Review
Evelyn Calderon Martinez, Samanta Landazuri-Navas, Esmeralda Vilchez, et al.
Journal of Clinical Medicine Research (2023) Vol. 15, Iss. 4, pp. 200-207
Open Access | Times Cited: 37
Application of Machine Learning Techniques to Assess Alpha-Fetoprotein at Diagnosis of Hepatocellular Carcinoma
Sergio Gil-Rojas, Miguel Suárez, Pablo Martínez-Blanco, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 1996-1996
Open Access | Times Cited: 6
Systemic inflammation with sarcopenia predicts survival in patients with gastric cancer
Yuying Liu, Guo‐Tian Ruan, Yi‐Zhong Ge, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 3, pp. 1249-1259
Closed Access | Times Cited: 21
Advances in post-operative prognostic models for hepatocellular carcinoma
Ziqin He, Xiaomin She, Ziyu Liu, et al.
Journal of Zhejiang University SCIENCE B (2023) Vol. 24, Iss. 3, pp. 191-206
Open Access | Times Cited: 11
Folate receptor 1 is a stemness trait-associated diagnostic and prognostic marker for hepatocellular carcinoma
Yuto Shiode, Takahiro Kodama, Yu Sato, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Latent class analysis‐derived classification for cancer‐specific death stratification of hepatocellular carcinoma
Xiaoyan Jiang, Qianyuan Zhang, Zhong Zheng, et al.
International Journal of Cancer (2025)
Closed Access
Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
Qianhui Xu, Hao Xu, Rongshan Deng, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Combining Pre- and Postoperative Lymphocyte–C-Reactive Protein Ratios Can Better Predict Hepatocellular Carcinoma Prognosis After Partial Hepatectomy
Hanghang Ni, Lu Zhan, Xi Huang, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 2229-2241
Open Access | Times Cited: 12
Prognostic and immune correlation evaluation of a novel cuproptosis-related genes signature in hepatocellular carcinoma
Zheng Zhou, Yusong Zhou, Dongbo Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Integrated analysis of intratumoral biomarker and tumor-associated macrophage to improve the prognosis prediction in cancer patients
Ming-Da Wang, Hao Xiang, Tianyu Hong, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Impact of body composition for patients with hepatocellular carcinoma who received atezolizumab plus bevacizumab therapy
Haruki Uojima, Makoto Chuma, Hisashi Hidaka, et al.
European Journal of Gastroenterology & Hepatology (2023) Vol. 35, Iss. 8, pp. 865-873
Closed Access | Times Cited: 4
Cost-effectiveness analysis of atezolizumab plus bevacizumab versus sorafenib in first line treatment for Chinese subpopulation with unresectable hepatocellular carcinoma
Chien-Yu Tseng, Yi‐Wen Tsai, Ming‐Neng Shiu
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Effect of multidisciplinary team care on patient survival in chronic hepatitis B or C hepatocellular carcinoma
Yu‐Chen Tseng, Pei‐Tseng Kung, Cheng‐Yuan Peng, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Combining Preoperative and Postoperative Inflammatory Indicators Can Better Predict the Recurrence of Hepatocellular Carcinoma After Partial Hepatectomy
Meilong Wu, Shizhong Yang, Xiaobin Feng, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 3231-3245
Open Access | Times Cited: 7
Machine learning integrations develop an antigen-presenting-cells and T-Cells-Infiltration derived LncRNA signature for improving clinical outcomes in hepatocellular carcinoma
Xiaodong Wang, Ji Chen, Lifan Lin, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
A Powerful Nomogram Based on the Novel D-Index to Predict Prognosis After Surgical Resection of Hepatocellular Carcinoma
Xia Du, Chengnan Guo, Xiaodong Bao
Cancer Management and Research (2021) Vol. Volume 13, pp. 2581-2594
Open Access | Times Cited: 5
Gene expression profiles contribute to robustly predicting prognosis in hepatocellular carcinoma
Long Liu, Yuhui Wang, Yuyuan Zhang, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 593-596
Open Access | Times Cited: 1
Prognostic Factors of Primary Liver Cancer
海棠 郑
Advances in Clinical Medicine (2024) Vol. 14, Iss. 10, pp. 105-111
Closed Access
Establishment of a clinical model based on vessels encapsulating tumour clusters that could efficiently predict recurrence of patients with hepatocellular carcinoma after curative hepatectomy
Meilong Wu, Ying Xiao, Yan Wang, et al.
Pathology (2024) Vol. 57, Iss. 3, pp. 320-327
Closed Access
Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study
Bingren Hu, Yi Yang, Jiangqiao Yao, et al.
Cancer Medicine (2024) Vol. 13, Iss. 24
Open Access
Dehydrocrenatidine Induces Liver Cancer Cell Apoptosis by Suppressing JNK-Mediated Signaling
Bharath Kumar Velmurugan, Ming‐Ju Hsieh, Chia‐Chieh Lin, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 402-402
Open Access | Times Cited: 1
Clinical and prognostic value of CT perfusion imaging parameters in patients with primary liver cancer after therapy.
Yiming Li, Yuzhou Li, Yuan Sui, et al.
PubMed (2022) Vol. 14, Iss. 1, pp. 320-327
Closed Access | Times Cited: 1
Analysis of the Prognosis Prediction Ability of a Necroptosis-Related Gene Signature and its Relationship With the Hepatocellular Carcinoma Immune Microenvironment Using Bioinformatics Analysis and Experimental Validation
Renguo Guan, Jie Mei, Rong Guo
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access
Page 1

Scroll to top